15 Jul 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/altamira-therapeutics-announces-allowance-of-japanese-patent-applicat-1048826
10 Nov 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/11/10/2778332/0/en/Altamira-Therapeutics-Announces-European-Patent-Office-Decision-to-Grant-for-Patent-Application-Covering-Intranasal-Betahistine.html
03 Jul 2019
// GLOBE NEWSWIRE
http://www.globenewswire.com/news-release/2019/07/03/1877879/0/en/Auris-Medical-Completes-Enrollment-of-Phase-1b-Proof-Of-Concept-Trial-of-AM-201-in-Antipsychotic-Induced-Weight-Gain.html
https://www.pharmacompass.com/pdf/news/ema-recommends-suspension-of-medicines-due-to-unreliable-studies-from-micro-therapeutic-research-labs-1503552764.pdf
12 May 2016
// HEALTH CANADA
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2016/58558r-eng.php